The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in support of the safety and efficacy of new dual-therapy (two-drug) regimens. The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in suppo.